ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 180 filers reported holding ADMA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,462,383 | +6.2% | 967,146 | +9.4% | 0.67% | +10.6% |
| Q2 2023 | $3,261,377 | -4.9% | 883,842 | -14.7% | 0.60% | -10.3% |
| Q1 2023 | $3,428,339 | -49.5% | 1,035,752 | -40.8% | 0.67% | -52.1% |
| Q4 2022 | $6,788,440 | +95.7% | 1,749,598 | +22.6% | 1.40% | +86.3% |
| Q3 2022 | $3,468,000 | +40.3% | 1,427,160 | +14.3% | 0.75% | +25.0% |
| Q2 2022 | $2,471,000 | – | 1,248,136 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |